A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban with Placebo for Reducing the Risk of Death, MI or Stroke in Subjects with HF and CAD

  • Brown, Martin (Primary Chief Investigator)
  • Butala, Radhika, (Research Coordinator)

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/1530/06/17